Acupuncture in cancer study reignites debate about controversial technique
暂无分享，去创建一个
[1] C. Moinpour,et al. Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] V. Napadow,et al. The National Cancer Institute's Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research Gaps. , 2017, Journal of the National Cancer Institute. Monographs.
[3] J. Mao,et al. Growth of Integrative Medicine at Leading Cancer Centers Between 2009 and 2016: A Systematic Analysis of NCI-Designated Comprehensive Cancer Center Websites. , 2017, Journal of the National Cancer Institute. Monographs.
[4] J. Unger,et al. Methods to Standardize a Multicenter Acupuncture Trial Protocol to Reduce Aromatase Inhibitor-related Joint Symptoms in Breast Cancer Patients. , 2015, Journal of acupuncture and meridian studies.
[5] H. Greenlee,et al. Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Aromatase Inhibitor-associated Joint Symptoms in Women with Early-stage Breast Cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.